Viral infections in allergy and immunology: How allergic inflammation influences viral infections and illness
File(s)1-s2.0-S0091674917313131-main.pdf (843.51 KB)
Published version
Author(s)
Type
Journal Article
Abstract
Viral respiratory tract infections are associated with asthma inception in early life and asthma exacerbations in older children and adults. Although how viruses influence asthma inception is poorly understood, much research has focused on the host response to respiratory viruses and how viruses can promote; or how the host response is affected by subsequent allergen sensitization and exposure. This review focuses on the innate interferon-mediated host response to respiratory viruses and discusses and summarizes the available evidence that this response is impaired or suboptimal. In addition, the ability of respiratory viruses to act in a synergistic or additive manner with TH2 pathways will be discussed. In this review we argue that these 2 outcomes are likely linked and discuss the available evidence that shows reciprocal negative regulation between innate interferons and TH2 mediators. With the renewed interest in anti-TH2 biologics, we propose a rationale for why they are particularly successful in controlling asthma exacerbations and suggest ways in which future clinical studies could be used to find direct evidence for this hypothesis.
Date Issued
2017-10-04
Date Acceptance
2017-07-31
Citation
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 140 (4), pp.909-920
ISSN
0091-6749
Publisher
MOSBY-ELSEVIER
Start Page
909
End Page
920
Journal / Book Title
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume
140
Issue
4
Copyright Statement
© 2017 The Authors. Published by Elsevier Inc. on behalf of the American Academy of
Allergy, Asthma & Immunology. This is an open access article under the CC BY-NCND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Allergy, Asthma & Immunology. This is an open access article under the CC BY-NCND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Sponsor
Asthma UK
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000412172900002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Grant Number
Asthma UK Centre
Subjects
Science & Technology
Life Sciences & Biomedicine
Allergy
Immunology
Virus
allergic inflammation
interferon
asthma
T-H(2)
RESPIRATORY SYNCYTIAL VIRUS
INNATE IMMUNE-RESPONSES
BRONCHIAL EPITHELIAL-CELLS
CYTOKINE SIGNALING 1
PLASMACYTOID DENDRITIC CELLS
SEVERE EOSINOPHILIC ASTHMA
RHINOVIRUS-INDUCED ASTHMA
PLACEBO-CONTROLLED TRIAL
BLOOD MONONUCLEAR-CELLS
HOSPITAL ADMISSIONS
T(H)2
Allergy and Immunology
Animals
Disease Progression
Humans
Hypersensitivity
Inflammation
Interferons
Respiratory Tract Infections
Th2 Cells
Virus Diseases
1107 Immunology
Publication Status
Published